Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond Anthony Low currently holds 37,748 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond Anthony Low has been a net neutral trader of SCLN stock. They have purchased $0 and sold $0 worth of shares.
Raymond Anthony Low's most recent insider trade was on Oct 13, 2017, when they sold 11,250 shares at $0.00 per share.
Raymond Anthony Low serves as Executive at SCICLONE PHARMACEUTICALS INC (SCLN). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Raymond Anthony Low holds the position of Executive at SCICLONE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Raymond Anthony Low has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Raymond Anthony Low was on Oct 13, 2017, when they sold $422.0K worth of SCLN shares. This transaction involved 37,748 shares at $11.18 per share.
Raymond Anthony Low currently owns 37,748 shares of SCICLONE PHARMACEUTICALS INC (SCLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond Anthony Low's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond Anthony Low has 10 Form 4 filings on record as an insider at SCICLONE PHARMACEUTICALS INC.
Set alerts for Raymond Anthony Low and 40,000+ other insiders.